logo
Plus   Neg
Share
Email

Celgene Prices $4.5 Bln Of Senior Unsecured Notes - Quick Facts

Celgene Corp. (CELG) said Thursday it has successfully priced four series of senior unsecured notes for an aggregate principal amount of $4.5 billion.

The company noted that of these notes, $500 million will mature in 2021 and will bear interest at an annual rate of 2.875 percent, $1.0 billion will mature in 2023 and will bear interest at an annual rate of 3.25 percent, $1.5 billion will mature in 2028 and will bear interest at an annual rate of 3.90 percent, and $1.5 billion will mature in 2048 and will bear interest at an annual rate of 4.55 percent.

The 2.875 percent notes due 2021, the 3.25 percent notes due 2023, the 3.90 percent notes due in 2028 and the 4.55 percent notes due in 2048 were priced to yield 2.891 percent, 3.303 percent, 3.942 percent and 4.587 percent, respectively.

Celgene said it expects to use the net proceeds from the offering to finance a portion of the acquisition of Juno Therapeutics, Inc. (JUNO) and to pay fees and expenses associated therewith and with the offering. The offering is expected to close on February 20, 2018.

Citigroup Global Markets Inc., Deutsche Bank Securities Inc., J.P. Morgan Securities LLC and Merrill Lynch, Pierce, Fenner & Smith Incorporated acted as joint book-running managers and representatives of the several underwriters.

by RTTNews Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Editors Pick
Nvidia Corp. (NVDA) Thursday reported a surge in its second-quarter profit, driven largely by a better-than-expected growth in revenues and strong margins. However, shares of the graphics chip maker slipped about 4 percent in extended session, as its revenue outlook for the current quarter fell short... The U.S. Food and Drug Administration Thursday approved the first generic version of Mylan's EpiPen for the emergency treatment of allergic reactions. Teva Pharmaceuticals gained the US regulator's approval to market its generic epinephrine auto-injector in 0.3 mg and 0.15 mg strengths. Shares of... Amazon.com Inc. (AMZN) is reportedly planning to acquire Landmark Theatres, as the e-commerce giant seeks to gain a foothold in the brick-and-mortar cinema industry. Bloomberg Thursday reported, citing people familiar with the situation, that Amazon is looking with other suitors to acquire the business...
Follow RTT